Products

PharmaForce develops, manufactures and markets multisource sterile pharmaceuticals, including Injectables, Ophthalmics and Otics. In December 2009, PharmaForce was acquired by Luitpold Pharmaceuticals, Inc. and its wholly owned subsidiary, American Regent, Inc. Please click here to view the complete American Regent product listing.

With more than 30 products in development, we are committed to satisfying your pharmaceutical needs.

Click on a product below for more specific product information

Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP <br> 6 mg/mL Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
6 mg/mL
Buprenorphine Hydrochloride Injection <br>0.3 mg (base)/mL Buprenorphine Hydrochloride Injection
0.3 mg (base)/mL
Ciprofloxacin Ophthalmic Solution, USP<br>0.3% as base Ciprofloxacin Ophthalmic Solution, USP
0.3% as base
Clonidine Hydrochloride Injection<br>100 mcg/mL Clonidine Hydrochloride Injection
100 mcg/mL
Clonidine Hydrochloride Injection<br>500 mcg/mL Clonidine Hydrochloride Injection
500 mcg/mL
Methylergonovine Maleate Injection, USP<br>0.2 mg/mL Methylergonovine Maleate Injection, USP
0.2 mg/mL
NICARdipine Hydrochloride Injection<br>2.5 mg/mL NICARdipine Hydrochloride Injection
2.5 mg/mL
Ofloxacin Ophthalmic Solution, USP <br>0.3% Ofloxacin Ophthalmic Solution, USP
0.3%
Pamidronate Disodium Injection <br>3 mg/mL Pamidronate Disodium Injection
3 mg/mL
Pamidronate Disodium Injection <br>9 mg/mL Pamidronate Disodium Injection
9 mg/mL
Progesterone Injection, USP<br>50 mg/mL Progesterone Injection, USP
50 mg/mL